Which statement about the prognosis of multiple sclerosis is accurate?

Which statement about the prognosis of multiple sclerosis is accurate?

• A. The prognosis varies; many patients experience relapses and remissions.
• B. A normal life expectancy is typical for most patients.
• C. The prognosis is always poor with rapid decline.
• D. The prognosis is unrelated to disease fluctuations.

Answer: (C)

In multiple sclerosis, prognosis varies and is closely tied to how active the disease is over time. Many people experience relapses—new or worsening neurological symptoms—and then partial or full recovery during remissions. This relapsing-remitting pattern is a common early course and is a key reason why the outlook isn’t fixed or uniform across all patients. Because MS can differ so much from person to person, describing the prognosis as always poor or as unrelated to fluctuations doesn’t fit. Some individuals manage relapses with little lasting disability, especially with early and effective treatment, while others may accumulate disability more gradually or transition to a progressive course. Life expectancy for many people with MS can be near normal, particularly with modern therapies and good overall care, but this is not universal and depends on disease activity, progression, and other health factors. So the statement that best reflects the typical understanding is that prognosis varies, and many patients experience relapses and remissions.

In multiple sclerosis, prognosis varies and is closely tied to how active the disease is over time. Many people experience relapses—new or worsening neurological symptoms—and then partial or full recovery during remissions. This relapsing-remitting pattern is a common early course and is a key reason why the outlook isn’t fixed or uniform across all patients.

Because MS can differ so much from person to person, describing the prognosis as always poor or as unrelated to fluctuations doesn’t fit. Some individuals manage relapses with little lasting disability, especially with early and effective treatment, while others may accumulate disability more gradually or transition to a progressive course. Life expectancy for many people with MS can be near normal, particularly with modern therapies and good overall care, but this is not universal and depends on disease activity, progression, and other health factors.

So the statement that best reflects the typical understanding is that prognosis varies, and many patients experience relapses and remissions.